You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder: A Randomized Controlled Trial
Steven A. Kaplan; Claus G. Roehrborn; Eric S. Rovner; Martin Carlsson; Tamara Bavendam; Zhonghong Guan
JAMA 2006; 296: 2319-2328.
[Abstract][Full text][PDF]
Original Contributions Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial
Ian M. Thompson Jr; Catherine M. Tangen; Jorge Paradelo; M. Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E. David Crawford
JAMA 2006; 296: 2329-2335.
[Abstract][Full text][PDF]
Preliminary Communications Effect of Testosterone Replacement Therapy on Prostate Tissue in Men With Late-Onset Hypogonadism: A Randomized Controlled Trial
Leonard S. Marks; Norman A. Mazer; Elahe Mostaghel; David L. Hess; Frederick J. Dorey; Jonathan I. Epstein; Robert W. Veltri; Danil V. Makarov; Alan W. Partin; David G. Bostwick; Maria Luz Macairan; Peter S. Nelson
JAMA 2006; 296: 2351-2361.
[Abstract][Full text][PDF]
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Karen H. Costenbader; Roberta Glass; Jing Cui; Nancy Shadick
JAMA 2006; 296: 2201.
[Extract][Full text][PDF]
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Peter E. Callegari; Thomas F. Schaible; Jerome A. Boscia
JAMA 2006; 296: 2202.
[Extract][Full text][PDF]
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid ArthritisReply
Tim Bongartz; Eric L. Matteson; Victor M. Montori; Alex J. Sutton; Michael Sweeting; Iain Buchan
JAMA 2006; 296: 2203-a-2204-a.
[Extract][Full text][PDF]
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Original Contributions Effect of Constraint-Induced Movement Therapy on Upper Extremity Function 3 to 9 Months After Stroke: The EXCITE Randomized Clinical Trial
Steven L. Wolf; Carolee J. Winstein; J. Philip Miller; Edward Taub; Gitendra Uswatte; David Morris; Carol Giuliani; Kathye E. Light; Deborah Nichols-Larsen; for the EXCITE Investigators
JAMA 2006; 296: 2095-2104.
[Abstract][Full text][PDF]